Braeburn Inc. Stock

BBRX

US10481L1008

Braeburn Inc is a pharmaceutical company, which focuses on the development and commercialization of long-acting medications for disorders of the central nervous system (CNS). The Company's implantable and injectable delivery mechanisms provide differentiated solutions for various diseases. The Company's therapeutic area is opioid addiction. The Company offers Probuphine. Its other therapeutic areas of focus include pain, schizophrenia and spasticity. The Company has approximately four additional late-stage product candidates in pipeline across different therapeutic areas, as well as approximately two earlier-stage product candidates. The Company's product portfolio combines approximately three primary delivery technologies with various compounds for the treatment of opioid addiction, pain, schizophrenia and spasticity: ProNeura implantable drug delivery technology, FluidCrystal injectable drug delivery platform and MedLaunch implant platform.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
BBRX Stock

-40%: Exceptional extension

SEIZE THE OFFER!

Delayed Nasdaq			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

Manager	Title	Age	Since
Michael M. Derkacz CEO	Chief Executive Officer	58	05/06/2017
David McIntyre DFI	Director of Finance/CFO	55	01/10/2016
Sonnie Kim CTO	Chief Tech/Sci/R&D Officer	-	01/06/2016

Director	Title	Age	Since
Seth Harrison CHM	Chairman	65	-
Argeris Karabelas BRD	Director/Board Member	73	01/09/2015
David McIntyre BRD	Director/Board Member	55	01/10/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRAEBURN INC.	-.--%	-.--%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+1.70%	+0.56%	+34.83%	-3.06%	78.37B
MODERNA, INC.	+12.27%	+17.89%	+585.18%	+72.54%	61.5B
CSL LIMITED	+0.86%	+3.17%	-9.76%	-28.70%	59.78B
SAMSUNG BIOLOGICS CO.,LTD.	+0.29%	-1.27%	-10.95%	+28.43%	46.53B
UCB	+1.92%	+0.76%	+4.33%	+154.99%	45.5B
BIOGEN INC.	+1.66%	+0.79%	+53.73%	-15.39%	31.84B
INCYTE CORPORATION	-0.53%	+2.01%	+44.05%	+111.95%	25.4B
INNOVENT BIOLOGICS, INC.	+6.00%	+5.73%	+11.24%	+170.18%	21.43B
SWEDISH ORPHAN BIOVITRUM AB	-0.76%	-1.03%	+57.98%	+103.49%	15.77B
Average	+2.34%	+2.65%	+85.63%	+66.05%	38.61B
Weighted average by Cap.	+3.09%	+3.43%	+108.27%	+47.95%

Braeburn Inc. Stock

Stocks

BBRX

US10481L1008

Pharmaceuticals

Managers and Directors: Braeburn Inc.

Biopharmaceuticals

Company Profile